Brands we represent
Sinomed (Innovation for Health) is a global medical device company engaged in research, development, production, and commercial distribution of interventional devices. Established in 2007 by Dr. Jianhua Sun and headquartered in Tianjin, China, SINOMED stands as a leading specialist in the meticulous research, development, production, and distribution of state-of-the-art interventional medical devices.
Sonosemi Medical Co., Ltd., founded in April 2020 in Shenzhen, the epicenter of scientific and technological advancements in China, is an innovative enterprise specializing in high-end pan-vascular interventional medical devices. Sonosemi Medical has designed its products in accordance with the open industry synergy strategy and the business logic of integrating research, production, and sales. The company’s products are centered on the clinical application scenarios of coronary artery disease, peripheral vascular disease, and structural heart disease. Its goal is to provide the cardiovascular disease diagnostic and treatment industry with a series of intelligent and precise product solutions..
Acotec., A Leading Global Innovative Medical Technology Enterprise focusing on the R&D and application of technology platforms in vascular interventional treatment. Relying on four unique technology platforms of drug-coating technology, RF ablation technology, polymer material technology, and aspiration platform technology, Acotec stays the course of reliable innovative ideas to continuously exploit unmet clinical needs, which provides brand-new treatment methods and reliable products for both doctors and patients.
With its diversified product portfolio, Acotec will continuously sustain innovation in vascular intervention treatment to struggle against vascular diseases. On the way of becoming one of the global leaders among medical technology enterprises, Acotect helps patients achieve long-term clinical benefits and improve their life quality by constantly bringing high-quality systemic vascular interventional treatment solutions to doctors and patients worldwide.
Demax., we focus on the R&D and production of disposable interventional therapy products for the cardiovascular system. Demax Group was established in 2004 and headquartered in Australia. It consists of Demax Medical Australia, Beijing Demax Medical, and Tianjin Demax Medical. In the past 17 years of development, Demax has always adhered to the core value of “Quality for Life.” We are putting product quality in the first place, which significantly winning the trust and support from more and more customers. In China, on average, about 3 out of 10 have enjoyed the services provided by Demx among the 300 million cardiovascular patients. .
Founded in 2015 by Yulin Weng and headquartered in Suzhou, Jiangsu Province, China, DK Medtech is dedicated to enhancing patients’ quality of life through cutting-edge technologies and innovative medical solutions. With a comprehensive product portfolio spanning coronary, peripheral, and neurovascular interventions, we deliver high-quality therapeutic options for global patients.
As a pioneer in full-range vascular interventions, DK Medtech has developed over 10 balloon catheter types including conventional balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Our proprietary Directional Scoring Technology demonstrates superior clinical benefits in coronary/peripheral scoring balloons and DCBs, outperforming imported counterparts in pre-market RCT studies.
Vivolight was founded in 2012. Vivolight is a Shenzhen-based medical device company with an established R&D center in Xi’an. Specializing in medical laser technology, we are dedicated to the independent development, global innovation, and in-house manufacturing of minimally invasive interventional diagnostic and therapeutic medical devices utilizing laser technology. By integrating cutting-edge photoelectric technology with medical and engineering expertise, we have achieved comprehensive mastery of core underlying technologies in laser diagnostics and therapeutics, fiber-optic catheters, and image processing. This has enabled us to develop a robust “diagnosis and treatment integrated” platform that spans multiple disease categories.
Our product portfolio encompasses a broad spectrum of applications, including cardiovascular and peripheral vascular diseases, among others. Several of our products have reached or even surpassed global benchmarks in terms of technological innovation and clinical efficacy.